Sort
46,585 grants matching “heart failure”
Plasma proteomics in CHS and population biology
$2,083,439Bruce M Psaty · University Of Washington · R01 · FY2020 · HL
INTEGRATIVE NEUROBIOLOGY OF CARDIOVASCULAR REGULATION
$2,082,306Francois M Abboud · University Of Iowa · P01 · FY2008 · HL
TRIP: Targeted Gene Therapy for the Treatment of Heart Failure
$2,082,299Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · P50 · FY2014 · HL
Immune Response-Mediated Regulation of Cardiomyocyte Growth and Renewal
$2,082,129Hesham Sadek · Ut Southwestern Medical Center · P01 · FY2024 · HL
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$2,080,616Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA
Native-Controlling Hypertension And Risk through Technology (Native-CHART)
$2,078,480Dedra S Buchwald · Washington State University · U54 · FY2016 · MD
NEURO-CIRCULATORY FUNCTION IN CHRONIC HEART DISEASE
$2,076,559Irving H Zucker · University Of Nebraska Medical Center · P01 · FY2008 · HL
Mechanisms of Myocardial Ischemia and Reperfusion
$2,074,703Univ Of Med/Dent Of Nj-Nj Medical School · P01 · FY2002 · HL
Biology and Therapeutics of Cardiovascular Peptides
$2,074,421John C Burnett · Mayo Clinic Rochester · P01 · FY2009 · HL
Vascular remodeling in patients with rare genetic disorders
$2,072,321Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Integrated Mechanisms of Cardiac Maladaptation
$2,071,418R John Solaro · University Of Illinois At Chicago · P01 · FY2020 · HL
JACKSON HEART STUDY (JHS) - COORDINATING CENTER (CC) - TO EXERCISE OPTION PERIOD THREE (3) AND REVISE CONTRACT ARTICLES.
$2,071,340Mario Sims · University Of Mississippi Med Ctr · N01 · FY2022 · HL
Barber-Pharmacist Coordination to Improve Blood Pressure Management in Black Men
$2,071,138Ronald G Victor · Cedars-Sinai Medical Center · R01 · FY2014 · HL
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
$2,068,764Joseph Eric Levitt · Stanford University · UH3 · FY2022 · HL
Heart Failure Clinical Research Network Coordinating Center
$2,068,753Kevin J Anstrom · Duke University · U10 · FY2016 · HL
Drug Metabolizing Enzymes In Humans And Animal Models
$2,068,287Joyce Goldstein · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
CORAL: Clinical Coordinating Center
$2,068,167University Of Toledo Health Sci Campus · U01 · FY2004 · HL
Mechanisms that Govern Cardiomyocyte Proliferation and Remuscularization following Ventricular Injury
$2,067,432Jianyi Zhang · University Of Alabama At Birmingham · P01 · FY2025 · HL
ARIC CLINICAL EXAMINATION CENTER
$2,067,159Gerardo Heiss · North Carolina Univ · N01 · FY2015 · HL
Aortic stiffness, wave reflection, and cerebrovascular flow pulsatility: relations with brain small vessel disease and cognitive function in a middle-aged cohort
$2,067,003Vasan S. Ramachandran · University Of Texas Hlth Science Center · RF1 · FY2023 · AG
Cardiac Myosin Binding Protein-C: Structure, Function, and Regulation
$2,066,980David M Warshaw · University Of Vermont & St Agric College · P01 · FY2011 · HL
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
$2,065,518Joseph Eric Levitt · Stanford University · UH3 · FY2020 · HL
NEURO-CIRCULATORY FUNCTION IN CHRONIC HEART DISEASE
$2,065,297Irving H Zucker · University Of Nebraska Medical Center · P01 · FY2006 · HL
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
$2,064,826Joseph Eric Levitt · Stanford University · UH3 · FY2021 · HL
Pharmacogenomic Evaluation of Antihypertensive Responses
$2,064,000Julie A. Johnson · University Of Florida · U01 · FY2010 · GM